Nuclear Oncology

Doses of iodine are referred by physicians for patients with thyroid gland problems. The I-131 is a radioactive isotope, emitting both beta particles and gamma radiation, with an average life of 8.04 days. The basic principle that justifies their use in therapy is unique physiological property owned by the thyroid gland to concentrate this element. This will deliver locally and directed a high dose of radiation in the functioning thyroid tissue respecting the rest of the body.

Ablative dose of iodine Central Nuclear Medicine, Nuclear Medicine thyroid gland of Central America, Thyroid Patient Therapy with I-131 is used both in benign, as in hyperthyroidism (Graves’ disease and functioning nodules) and some cases of multinodular goiter non-toxic and well-differentiated cancer (papillary or follicular) thyroid, both locally and advanced.

The indication, dosing and timing of radiation treatment should be taken in conjunction with the endocrinologist and surgeon and specialist in nuclear medicine. The only contra-indication for treatment with I-131 is pregnancy. Therefore, this possibility should be ruled out forever in every woman of childbearing age.